KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities